These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 462395)

  • 21. [The prospective evolution of the efficacy of antiarrhythmia therapy in paroxysmal supraventricular tachycardia in patients with the ventricular pre-excitation syndrome].
    Fomina IG; Iankin VV
    Klin Med (Mosk); 1992 Jan; 70(1):26-32. PubMed ID: 1608203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of the association of acetyldigitoxin and disopyramide in the attack treatment of complete tachyarrhythmia due to auricular fibrillation].
    Lambert B
    Mars Med; 1971; 108(12):851-3. PubMed ID: 5145502
    [No Abstract]   [Full Text] [Related]  

  • 23. Mental distress in patient on disopyramide.
    Falk RH; Nisbet PA; Gray TJ
    Lancet; 1977 Apr; 1(8016):858-9. PubMed ID: 67366
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of verapamil and disopyramide phosphate on the termination, reinduction and long-term prevention of paroxysmal supraventricular tachycardia].
    Tsuchioka Y; Nakagawa H; Yamagata T; Sakura E; Hashimoto M; Okamoto M; Matsuura H; Kajiyama G
    Kokyu To Junkan; 1990 Mar; 38(3):243-8. PubMed ID: 2109870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serendipitous relief with disopyramide of phobia for flying.
    Lewis DO
    Am J Psychiatry; 1983 Oct; 140(10):1387. PubMed ID: 6624986
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous disopyramide in myocardial infarction: a haemodynamic study.
    Marrott PK; Nairn PL; Hill PD; Turner G; Sharman J
    N Z Med J; 1983 Jan; 96(723):4-7. PubMed ID: 6571755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined effects of cordarone and ritmilen on the contractile function of the myocardium after intravenous and oral administration of loading doses].
    Gushchin IV; Gimrikh EO; Volkova TG; Chernov VI
    Kardiologiia; 1988 Oct; 28(10):103-4. PubMed ID: 3226038
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experiences with the antiarrhythmic therapy using disopyramide].
    Hombach V; Freyland MD; Steffel D; Braun V; Höpp HW; Zanker R; Behrenbeck DW; Tauchert M; Hilger HH
    Med Welt; 1981 Apr; 32(14):458-64. PubMed ID: 7219159
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of supraventricular paroxysmal tachycardia by intravenous administration of ATP].
    Nesterov IuI; Kiselev AG; Suvorova LI; Trushina TS; Boĭko VI
    Klin Med (Mosk); 1989 Mar; 67(3):87-8. PubMed ID: 2664342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of paroxysmal supraventricular tachycardia and tachyarrhythmia with verapamil].
    Penkov N; Penev A; Kaponov Kh
    Vutr Boles; 1984; 23(1):63-9. PubMed ID: 6730453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention by Propranolol of paroxysmal tachycardia of supraventricular origin. Long-term results].
    Bory M; Poggi L; d' Journo J; Serradimigni A; Audier M
    Arch Mal Coeur Vaiss; 1970 Feb; 63(2):174-81. PubMed ID: 4985972
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical studies of Norpace. Summarizing remarks.
    Fowler NO
    Angiology; 1975 Jan; 26(1 Pt 2):154-5. PubMed ID: 1090216
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of disopyramide and atenolol in the therapy of stabilized ventricular extrasystole in patients with mitral valve prolapse].
    Capucci A; Naccarella F; Catena G; Lamberti C; Marchesini B; Bracchetti D; Magnani B
    G Ital Cardiol; 1981; 11(4):498-505. PubMed ID: 6169581
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical studies of Norpace (Part V).
    Cook WR
    Angiology; 1975 Jan; 26(1 Pt 2):140-1. PubMed ID: 1115401
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative analysis of electrophysiologic effect of metoprolol and disopyramide, acting alone or in combination in patients with supraventricular tachycardia and Wolff-Parkinson-White syndrome.
    Bobrov VA; Frolov AI; Mitchenko EI; Galichansky IV; Zinchenko YuV
    Rev Port Cardiol; 1994 Mar; 13(3):221-5. PubMed ID: 8049089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Termination of paroxysmal supraventricular tachycardia with oral diltiazem.
    Pauszek ME
    Indiana Med; 1991 May; 84(5):318-20. PubMed ID: 2061599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Disopyramide in the therapy and prevention of chronic atrial fibrillation. Study of 50 cases].
    Pellegrino L; Prencipe D
    Minerva Cardioangiol; 1973 Dec; 21(12):827-32. PubMed ID: 4780271
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical studies of Norpace (Part IV).
    Jutzy RV
    Angiology; 1975 Jan; 26(1 Pt 2):138-9. PubMed ID: 803798
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cordarone in the maintenance of sinus rhythm: prevention of paroxysmal atrial fibrillation and of supraventricular paroxysmal tachycardia].
    Zagatti G; Benzoni A; Caturelli G
    Arch Maragliano Patol Clin; 1974; 30(2):245-9. PubMed ID: 4480711
    [No Abstract]   [Full Text] [Related]  

  • 40. [Efficiency of antiarrhythmic drugs of class 1C and isoptin in paroxysmal supraventricular tachycardia].
    Koshumbaeva KM; Tulenov MT; Belokopit IN
    Klin Med (Mosk); 2002; 80(2):57-60. PubMed ID: 11898726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.